Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,219 | 25,199 | 37,311 | 36,180 | 66,963 |
| Marketable Securities | 29,095 | 72,641 | 69,744 | 70,372 | 57,399 |
| Other current assets | 0 | 0 | 2,500 | 2,403 | 2,266 |
| TOTAL | $88,476 | $100,205 | $111,667 | $111,580 | $130,287 |
| Non-Current Assets | |||||
| PPE Net | 2,210 | 2,393 | 2,653 | 3,518 | 3,788 |
| Other Non-Current Assets | 4,989 | 5,133 | 5,254 | 5,511 | 6,070 |
| TOTAL | $7,200 | $7,526 | $7,907 | $9,029 | $9,858 |
| Total Assets | $95,675 | $107,730 | $119,574 | $120,609 | $140,145 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,619 | 3,861 | N/A | 103 | 408 |
| Accounts payable and accrued liabilities | 2,697 | 1,782 | 2,546 | 1,878 | 3,615 |
| Accrued Expenses | 5,496 | 10,093 | 13,368 | 15,088 | 17,743 |
| Other current liabilities | 134 | 134 | 127 | 599 | 803 |
| TOTAL | $15,118 | $17,008 | $17,144 | $18,737 | $23,605 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,728 | 15,636 | 18,551 | 18,373 | 18,199 |
| Other Non-Current Liabilities | 5,674 | 5,978 | 6,251 | 6,540 | 6,823 |
| TOTAL | $19,402 | $21,615 | $24,802 | $24,913 | $25,023 |
| Total Liabilities | $34,520 | $38,622 | $41,945 | $43,650 | $48,628 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,171 | 4,171 | 4,170 | 4,170 | 4,164 |
| Common Shares | 13 | 0 | 13 | 13 | 13 |
| Retained earnings | -359,171 | -349,734 | -339,473 | -337,297 | -320,159 |
| Other shareholders' equity | -170 | -62 | -9 | -5 | -29 |
| TOTAL | $61,155 | $69,108 | $77,629 | $76,959 | $91,517 |
| Total Liabilities And Equity | $95,675 | $107,730 | $119,574 | $120,609 | $140,145 |